|
|
|
By Sunil Gupta, CDISC, SAS, and R SME, trainer, and author | Double programming has been the gold standard for validation, but technological advancements and improved sponsor oversight of CRO deliverables have introduced more efficient and reliable alternatives. | |
|
|
|
| Top HEOR Trends | Article | ISPOR—The Professional Society for Health Economics and Outcomes Research | Real-world evidence (RWE) offers insights into the effectiveness of medical treatments in everyday settings, with various stakeholders utilize RWE to enhance healthcare. |
|
|
| Clinical Trials In The Age Of Cost Caps | Article | By Charlie Paterson, PA Consulting | On February 7, 2025, the NIH introduced a pivotal policy (NOT-OD-25-068), capping indirect cost recovery at 15% for research grants. |
|
|
| Parkinson's Disease: Leveraging Wearable DHTs | Article | ActiGraph | Wearable DHTs offer a solution to the challenges of measuring Parkinson's disease in clinical trials. Discover how these technologies can improve outcome measures and accelerate drug development. |
|
|
| eCOA Evolution: Have We Overcomplicated It? | Article | Castor | eCOA has evolved from simple data collection to complex patient engagement platforms, raising concerns about added complexity. Explore innovative tools aimed at simplifying this complexity. |
|
|
|
|
|
| 6 Ways Lab Data Can Improve Clinical Trials | Article | Quest Diagnostics | Explore six key ways laboratory data strengthens the clinical trial process, focusing on how RWD enhances patient recruitment, accelerates screening workflows, and improves overall study outcomes. |
|
|
